Brain implants for speech, neurological effects of COVID-19, and motor recovery after stroke are among the topics that researchers from UC San Francisco (UCSF) will be presenting at this year’s annual ...

At the conference, Neurophet shared its latest clinical research progress utilizing its personalized tDCS solutions for treating severe brain disorders. The company presented the following research ...

MALVERN, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...

LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation ...